Range Financial Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.51M | Sell |
13,582
-2,369
| -15% | -$263K | 0.59% | 57 |
|
|
2025
Q1 | $1.79M | Buy |
15,951
+5,325
| +50% | +$597K | 0.79% | 37 |
|
|
2024
Q4 | $982K | Buy |
10,626
+7,868
| +285% | +$727K | 0.45% | 72 |
|
|
2024
Q3 | $231K | Sell |
2,758
-5,254
| -66% | -$440K | 0.32% | 71 |
|
|
2024
Q2 | $550K | Sell |
8,012
-5,021
| -39% | -$344K | 0.28% | 104 |
|
|
2024
Q1 | $955K | Buy |
13,033
+3,634
| +39% | +$266K | 0.5% | 67 |
|
|
2023
Q4 | $761K | Sell |
9,399
-95
| -1% | -$7.7K | 0.46% | 72 |
|
|
2023
Q3 | $711K | Sell |
9,494
-256
| -3% | -$19.2K | 0.47% | 72 |
|
|
2023
Q2 | $751K | Sell |
9,750
-3,948
| -29% | -$304K | 0.48% | 76 |
|
|
2023
Q1 | $1.14M | Sell |
13,698
-923
| -6% | -$76.6K | 0.74% | 49 |
|
|
2022
Q4 | $1.26M | Sell |
14,621
-1,415
| -9% | -$121K | 0.86% | 37 |
|
|
2022
Q3 | $989K | Buy |
16,036
+9
| +0.1% | +$555 | 0.76% | 51 |
|
|
2022
Q2 | $991K | Sell |
16,027
-223
| -1% | -$13.8K | 0.72% | 57 |
|
|
2022
Q1 | $966K | Buy |
16,250
+1,373
| +9% | +$81.6K | 0.62% | 62 |
|
|
2021
Q4 | $1.08M | Sell |
14,877
-31
| -0.2% | -$2.25K | 0.71% | 52 |
|
|
2021
Q3 | $1.04M | Buy |
14,908
+243
| +2% | +$17K | 0.75% | 53 |
|
|
2021
Q2 | $1.01M | Buy |
14,665
+4,439
| +43% | +$306K | 0.75% | 52 |
|
|
2021
Q1 | $661K | Buy |
+10,226
| New | +$661K | 0.6% | 71 |
|